Interaction of exercise training and n-3 fatty acid supplementation on postprandial lipemia.
The effect of combining omega-3 fatty acid (n-3 FA) supplementation and exercise training treatment on postprandial lipemia (PPL) has not been studied. The purpose of this study was to examine the interaction of n-3 FA and exercise training in attenuating PPL after a high-fat meal. Previously sedentary, overweight, subjects (n=22; 12 women, 10 men, BMI 26.6+/-0.7 kg/m2) were randomly assigned to one of two treatment groups: n-3 FA supplementation alone (FO, n=10) or n-3 FA supplementation plus exercise training (FO+ExTr, n=12). Both groups consumed 4 g/d n-3 FA, and one group also exercise trained for 45 min/d, 5d/week of brisk walking and (or) jogging at 60% VO2 max. Before and after 4 weeks of treatment, subjects performed a baseline PPL and a PPL following a single session of exercise (ExPPL). PPL was assessed by triglyceride (TG) area under the curve (AUC) and peak TG response (TGpeak). A two-way analysis of variance (ANOVA) with repeated measures was used to compare results from treatments for baseline and exercise trials. FO alone reduced PPL and Ex PPL, and FO+ExTr attenuated the ExPPL response measured as total AUC and TGpeak. There was no significant main effect for group or group by time interaction for baseline PPL or ExPPL. Fasting high-density lipoprotein cholesterol (HDL-C) and HDL2-C (i.e., subfraction 2) concentrations were significantly increased in the FO+ExTr group after the treatments. These results suggest that n-3 FA supplementation reduced PPL in sedentary subjects. Exercise training has no interference or additive effects with n-3 FA supplementation in attenuating PPL, but combined treatments may be additive in raising high-density lipoprotein cholesterol.
Thomas
Tom R
TR
Exercise Physiology Program, Department of Nutritional Sciences, 113 McKee Gymnasium, University of Missouri, Columbia, MO 65211, USA. thomastr@missouri.edu
Liu
Ying
Y
Linden
Melissa A
MA
Rector
R Scott
RS
D000328:Adult; D008076:Cholesterol, HDL / Q000097:blood; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000097:blood; D015118:Eicosapentaenoic Acid / Q000097:blood; D015444:Exercise / Q000502:physiology*; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage*; D005260:Female; D005502:Food; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D015525:Fatty Acids, Omega-3; D014280:Triglycerides; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid